XML 49 R4.htm IDEA: XBRL DOCUMENT v3.2.0.727
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Operating costs and expenses:        
Research and development $ 47,977 $ 6,315 $ 79,555 $ 11,416
Patent costs 50,148 27,382 112,423 64,164
General and administrative 2,001,706 352,431 3,304,152 597,087
Total operating costs and expenses 2,099,831 386,128 3,496,130 672,667
Operating loss (2,099,831) (386,128) (3,496,130) (672,667)
Other income (expense):        
Interest income (expense), net 2,101 (4,944) 4,305 (4,739)
Other income     7,091  
Total other income (expense) 2,101 (4,944) 11,396 (4,739)
Net loss (2,097,730) (391,072) (3,484,734) (677,406)
Cumulative preferred stock dividends 178,286 147,337 327,569 294,785
Accretion of discount on Series C preferred stock 31,465   63,283  
Net loss applicable to common stockholders $ (2,307,481) $ (538,409) $ (3,875,586) $ (972,191)
Net loss per common share - basic and diluted (in dollars per share) $ (4.18) $ (1.18) $ (7.62) $ (2.14)
Weighted average common shares outstanding - basic and diluted (in shares) 551,912 456,408 508,645 453,901